Search the Blog

Translational Research and the Latest Prostate Cancer Discoveries

At the BC Cancer Agency I wear a number of hats: first, I’m a medical oncologist which is a sub-specialist in the drug treatment of cancer. I’m further sub-sub-specialized in that I mainly treat patients with genitourinary (GU) cancers (cancers of the prostate, bladder, testis, kidney and adrenal gland).

I’m also a researcher and study outcomes, biomarkers, and conduct clinical trials...

A Look Into the Future: How to Turn a Wealth of Data Into Better Treatments for Patients

Time has flown and this is already my last post. I want to take the opportunity to look into the future and explain with a little more detail the new directions I see for the research field, the Centre for Lymphoid Cancer and my own laboratory.

In the last decade, we have generated an exciting wealth of data for lymphoid cancer, describing changes on the molecular level. From this, we...

“Somatic Mutations in Cancer Genomes” or “The Spelling Errors that Cause Cancer”

Today I would like to introduce you to the research that I do in my laboratory and elaborate on my motivation to conduct clinically-relevant research.

The timing of my early career was just right to match my research interests with the direction the whole field was moving. Major breakthroughs in cancer research over the  past decade have connected basic science with clinical research...

A Few Thoughts on the Future of Cancer Research and Care

Hi - this week I was hoping to talk a little about how cancer treatment may look five years from now. Honestly speaking, that is something that is really difficult to predict. One of the remarkable things about science and research is that you really do not know where it is going to take you. We often try a treatment for one type of cancer and then it ends up working for a completely different...

BrainCare Part II: World-Class Expertise and Technology

Without embellishment, BrainCare has managed to create a brain tumour diagnosis/surgery/treatment paradigm that I believe is unique in the world.  Perhaps this is simply due to the luck of timing, but as they say, the harder you work, the luckier you get.

There are three foundations:

Firstly, the BC Cancer Agency has a world-class Functional Imaging Program. Under the supervision...

A Glimpse into the Future of Cancer Research and Care

Dear readers - thank you so much for returning to my fourth and final blog post. This week I have an opportunity to reflect on some of the revolutions in cancer treatment that I have personally witnessed over the past two decades and speak a little on what I think our future might look like.

I graduated from medical school in 1993, and started training in radiation oncology that same...

BC Cancer Agency: The Place for Cutting-Edge Research

Hello everyone,

Right now is a very exciting time for cancer research in British Columbia for several reasons, one of them being the huge advances that have been made in the technology we use at the BC Cancer Agency.

The BC Cancer Agency is a world leader in genomics research, which is the study of the genetic changes that lead to cancer development and growth. In the past decade...

Current Pancreatic Cancer Research at the BC Cancer Agency

Hello everyone,

In this week’s post I’d like to tell you about some of the areas of research we’re working on to improve our ability to diagnose and treat pancreatic cancer. As many of you are aware, pancreatic cancer is a common and very aggressive cancer, and there are several reasons why we have a difficult time treating it: one issue is that pancreatic cancer often doesn’t cause...

Genomics is just the beginning

When I first started working in cancer genetics, we used old technologies to indentify genetic alterations in tumours. It was challenging work and we were often left in what felt like a no-man’s land. But the discoveries and disease-specific genetic alterations found then are now recognized world-wide as the drivers of those diseases.

These days, the BC Cancer Agency Genome Sciences...


Subscribe to Genomics